ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2016 American Transplant Congress » Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies

Date: Saturday, June 11, 2016

Time: 5:30pm-7:30pm

Location: Halls C&D

Session Type: Poster Session

Meeting: 2016 American Transplant Congress

5:30pm-7:30pm
3D-FLM (First, Last, Max): A Novel Summative Measure of Hepatocellular Carcinoma (HCC) Tumor Burden Predicts HCC Recurrence After Liver Transplantation (LT).

E. Nordstrom,1 J. Dodge,2 J. Gralla,1 K. Campbell,1 C. Palmer,1 S. Biggins.1

5:30pm-7:30pm
A Comparative Intention-to-Treat Analysis of Liver Transplantation for HCC – Living Donor Liver Transplant vs. Deceased Donor Liver Transplant.

K. Tomiyama, N. Goldaracena, A. Barbas, M. Dib, G. Levy, L. Lilly, A. Ghanekar, I. McGilvray, E. Renner, M. Bhat, M. Selzner, M. Cattral, N. Selzner, P. Greig, D. Grant, G. Sapisochin.

5:30pm-7:30pm
Assessing the Role of Everolimus in Reducing Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation for Patients within UCSF Criteria: Re-Inventing the Role of Mammalian Target of Rapamycine Inhibitors.

L.-B. Jeng, A. Thorat, H.-R. Yang, T.-H. Chen, S.-C. Hsu.

5:30pm-7:30pm
Clinical Analysis of Patients with Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation.

D. Kim, G. Na, T. Hong, Y. You.

5:30pm-7:30pm
Clinical Significance of Solitary Pulmonary Nodules in Liver Transplant Recipients with Hepatocellular Carcinoma.

O. Serrano,1 A. Bangdiwala,2 D. Vock,2 V. Kirchner,1 K. Yadav,1 A. Pugalendhi,1 E. Minja,1 T. Dunn,1 E. Finger,1 A. Matas,1 R. Kandaswamy,1 W. Payne,1 T. Pruett,1 S. Chinnakotla.1

5:30pm-7:30pm
Comparative Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma (HCC-CCA) Undergoing Liver Transplantation: A Single Center Matched Cohort Analysis.

K. Lunsford, M. Harlander-Locke, J. Gornbein, A. Zarrinpar, F. Kaldas, H. Yersiz, D. Farmer, R. Busuttil, V. Agopian.

5:30pm-7:30pm
Dysfunctional Production of Adipocytokines in Obesity Results in Inferior Oncologic Outcomes from Hepatocellular Carcinoma Following Liver Transplantation.

A. Mathur, E. Presbyskowski, D. Carpenter, E. Zorn, J. Guarrera, B. Samstein, A. Griesemer, K. Halazun, Y. Veras, K. Tomoaki, J. Emond.

5:30pm-7:30pm
Elevated Lung Shunt Fraction as an Independent Predictor of Local Disease Progression and Metastasis in Hepatocellular Carcinoma.

T. Sandow,1 D. DeVun,1 P. Gulotta,1 H. Bohorquez,2 D. Kirsch.1

5:30pm-7:30pm
Intraoperative Blood Loss Is a Promoter of Early Tumor Recurrence in Liver Transplant Patients with High Risk Hepatocellular Carcinoma.

A. Kornberg,1 U. Witt,1 J. Kornberg,2 H. Friess,1 K. Müller,3 K. Thrum.4

5:30pm-7:30pm
Metabolomic Profiles of Hepatocellular Carcinoma and Cirrhotic Patients Before and After Transplantation.

C. Desai,1 R. Varghese,2 S. Robertazzi,1 C. Di Poto,2 A. Ferrarini,2 C. Tu,2 R. Girlanda,1 K. Khan,1 T. Fishbein,1 H. Ressom.2

5:30pm-7:30pm
Occult Multifocal Hepatocellular Carcinoma in Surgical Patients.

D. Aufhauser Jr,1 E. Sadot,2 D. Murken,1 K. Eddinger,1 D. Goldberg,3 E. Furth,4 P. Abt,1 R. DeMatteo,2 M. Levine.1

5:30pm-7:30pm
Pre-Transplant Intra-Arterial Liver Directed Therapy Does Not Increase the Risk of Hepatic Arterial Misadventures in Liver Transplantation.

J. Kallini,2 A. Gabr,2 R. Salem,2 R. Lewandowski,2 T. Baker.1

5:30pm-7:30pm
Predictive Value of Preoperation Serum Gamma-Glutamyltranspeptidase for Hepatocellular Carcinoma Prognosis After Liver Transplantation.

S. Fu, Q. Zhao, M. Chen, L. Wu, Q. Ren, F. Ji, Z. Guo, X. He.

5:30pm-7:30pm
Selection of Patients with Solitary Lesion of Hepatocellular Cancer for Liver Transplantation.

M. Grąt,1 J. Stypułkowski,1 W. Patkowski,1 K. Wronka,1 M. Wasilewicz,2 K. Grąt,3 L. Masior,1 M. Krasnodębski,1 Z. Lewandowski,4 M. Krawczyk.1

5:30pm-7:30pm
Transplantation for Hepatocellularcarcinoma Is There a Tumor Size Limit?

A. Daoud, L. Teeter, M. Ghobrial, E. Graviss, S. Mogawer, A. Sholkamy, M. Alshazly, H. Monsour, A. Gaber.

5:30pm-7:30pm
Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.

A. Gupta, M. Ramsay, G. Saracino, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Klintmalm, P. Kim.

5:30pm-7:30pm
Which Is the Predictable Value of Post-Transplant HCC Recurrence Between Tumor-Related Factors at the Initial Diagnosis and the Transplantation?

J. Lee,1,2 J. Lee,1 J. Lee,3 S. Song,1 J. Lee,1 S.-K. Kwon,1 M. Ju,1,2 M. Kim,1,2 G. Choi,1,2 J. Choi,1,2 S. Kim,1,2 D. Joo.1,2

5:30pm-7:30pm
Which Is the Predictable Values of Post-Transplant Hepatocellular Carcinoma Recurrence in Patients Received Down Staging Therapy or Bridging Therapy?

S. Song, J. Lee, S.-K. Kwon, J. Lee, J. Lee, D. Han, G. Choi, M. Kim, J. Choi, S. Kim, D. Joo.

« View all sessions from the 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences